Market Closed -
Euronext Paris
11:29:20 2024-04-29 EDT
|
5-day change
|
1st Jan Change
|
0.3925
EUR
|
+4.95%
|
|
+5.80%
|
-11.20%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
148.9
|
144.7
|
161.1
|
109.8
|
55.83
|
18.7
|
18.7
|
Enterprise Value (EV)
1 |
148.9
|
144.7
|
133
|
89.38
|
53.61
|
22.05
|
18.7
|
P/E ratio
|
-8.08
x
|
-7.02
x
|
-8.06
x
|
-2.18
x
|
-1.78
x
|
-1.25
x
|
-1.56
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
37
x
|
21
x
|
18.1
x
|
15.2
x
|
17.1
x
|
5.25
x
|
2.03
x
|
EV / Revenue
|
37
x
|
21
x
|
14.9
x
|
12.4
x
|
16.4
x
|
5.25
x
|
2.03
x
|
EV / EBITDA
|
-7.29
x
|
-12.9
x
|
-26.5
x
|
-5.38
x
|
-2.35
x
|
-1.7
x
|
-
|
EV / FCF
|
-
|
-
|
-24,567,989
x
|
-4,834,123
x
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-0%
|
-0%
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
1.59
x
|
1.45
x
|
1.04
x
|
-
|
-
|
Nbr of stocks (in thousands)
|
29,719
|
33,231
|
37,030
|
42,991
|
49,845
|
50,011
|
50,011
|
Reference price
2 |
5.010
|
4.355
|
4.350
|
2.555
|
1.120
|
0.3740
|
0.3740
|
Announcement Date
|
19-03-06
|
20-03-06
|
21-03-01
|
22-04-28
|
23-03-20
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
4.027
|
6.9
|
8.9
|
7.233
|
3.271
|
4.2
|
9.2
|
EBITDA
1 |
-20.42
|
-11.21
|
-5.017
|
-16.61
|
-22.86
|
-16.4
|
-
|
EBIT
1 |
-20.67
|
-18.33
|
-6.76
|
-46.01
|
-33.96
|
-16.46
|
-14.8
|
Operating Margin
|
-513.24%
|
-265.68%
|
-75.96%
|
-636.11%
|
-1,038.18%
|
-408.01%
|
-160.87%
|
Earnings before Tax (EBT)
1 |
-18.28
|
-22.78
|
-18.07
|
-47.4
|
-30.29
|
-14.95
|
-14.8
|
Net income
1 |
-18.39
|
-18.92
|
-18.1
|
-43.76
|
-27.76
|
-14.97
|
-14.8
|
Net margin
|
-456.69%
|
-274.23%
|
-203.35%
|
-605.02%
|
-848.64%
|
-371.09%
|
-160.87%
|
EPS
2 |
-0.6200
|
-0.6200
|
-0.5400
|
-1.170
|
-0.6300
|
-0.3000
|
-0.2400
|
Free Cash Flow
|
-
|
-
|
-5.412
|
-18.49
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-60.81%
|
-255.62%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-03-06
|
20-03-06
|
21-03-01
|
22-04-28
|
23-03-20
|
-
|
-
|
Fiscal Period: December |
2019 S1
|
2019 S2
|
2020 S1
|
2020 S2
|
2021 Q1
|
2021 Q2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
---|
Net sales
1 |
5.59
|
1.265
|
2.4
|
6.6
|
0.6
|
0.722
|
1.322
|
2.4
|
3.478
|
0.7
|
1.43
|
0.8
|
1.041
|
0.9
|
1.1
|
1.2
|
4.3
|
1.5
|
1.6
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-13.04
|
-
|
0.868
|
-
|
-
|
-12.15
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-3.92
|
-
|
-4.5
|
-4.4
|
Operating Margin
|
-
|
-1,030.67%
|
-
|
13.15%
|
-
|
-
|
-919.21%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-326.67%
|
-
|
-300%
|
-275%
|
Earnings before Tax (EBT)
|
-
|
-18.23
|
-
|
-3.489
|
-
|
-
|
-11.74
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-3.62
|
-
|
-4.5
|
-4.4
|
Net income
|
-
|
-18.17
|
-
|
-3.491
|
-
|
-
|
-11.71
|
-
|
-
|
-
|
-17.01
|
-
|
-
|
-
|
-
|
-3.62
|
-
|
-4.5
|
-4.4
|
Net margin
|
-
|
-1,436.44%
|
-
|
-52.89%
|
-
|
-
|
-886.01%
|
-
|
-
|
-
|
-1,189.23%
|
-
|
-
|
-
|
-
|
-301.67%
|
-
|
-300%
|
-275%
|
EPS
2 |
-0.0300
|
-0.5900
|
-
|
-
|
-
|
-
|
-0.3200
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.0700
|
-0.0700
|
-
|
-0.0800
|
-0.0700
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19-09-26
|
20-03-06
|
20-09-10
|
21-03-01
|
21-06-24
|
21-09-24
|
21-09-24
|
22-01-28
|
22-04-28
|
22-09-16
|
22-09-16
|
22-12-20
|
23-03-20
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
9.24
|
-
|
Net Cash position
1 |
-
|
-
|
28.1
|
20.5
|
2.22
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-0.5633
x
|
-
|
Free Cash Flow
|
-
|
-
|
-5.41
|
-18.5
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-17%
|
-17.2%
|
-49.6%
|
-43.4%
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
2.730
|
1.760
|
1.070
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-0.1800
|
-
|
-
|
-
|
-
|
Capex
1 |
0.23
|
0.06
|
0.02
|
0.01
|
0.04
|
0.12
|
0.19
|
Capex / Sales
|
5.66%
|
0.91%
|
0.22%
|
0.11%
|
1.28%
|
3.03%
|
2.07%
|
Announcement Date
|
19-03-06
|
20-03-06
|
21-03-01
|
22-04-28
|
23-03-20
|
-
|
-
|
Last Close Price
0.374
EUR Average target price
1
EUR Spread / Average Target +167.38% Consensus |
1st Jan change
|
Capi.
|
---|
| -11.20% | 19.97M | | +4.06% | 70.44B | | +10.97% | 8.94B | | -14.44% | 4.75B | | +41.60% | 4.5B | | +5.96% | 3.85B | | +23.46% | 2.38B | | -19.32% | 2.34B | | -27.04% | 2.2B | | +7.97% | 1.96B |
Specialty & Advanced Pharmaceuticals
|